Kainos Medicine, Inc. (KOSDAQ:284620)

Kainos Medicine Revenue

Kainos Medicine had revenue of 370.34M KRW in the quarter ending March 31, 2026, with 0.40% growth. This brings the company's revenue in the last twelve months to 1.17B, up 42.97% year-over-year. In the year 2025, Kainos Medicine had annual revenue of 1.17B with 98.46% growth.

• Revenue (ttm): 1.17B
• Revenue Growth: +42.97%
• P/S Ratio: 30.31
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 35.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	581.27M	98.46%
Dec 31, 2024	590.37M	323.05M	120.85%
Dec 31, 2023	267.31M	137.29M	105.59%
Dec 31, 2022	130.02M	-1.53B	-92.18%
Dec 31, 2021	1.66B	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error